| 3/28/2024 | 30049089 | New medicine: Irprestan 150mg (Irbesartan 150mg) Box of 2 blisters x 14 tablets. Film-coated tablets. Lot: 145861;146363. Manufacturer: November 15, 2023. HD: November 15, 2025. Registration number: VN-21977-19. Manufacturer: Balkanpharma - Dupnitsa AD | XXXXXXXXXX | 52196 | UNK | 91891.058 | Bulgaria | NA |
| 3/28/2024 | 30049089 | New medicine: Irprestan 150mg (Irbesartan 150mg) Box of 2 blisters x 14 tablets. Film-coated tablets. Lot: 145858;145859;145860;145862. Producer: 12; 13; 14; November 16, 2023. HD: 12; 13; 14; November 16, 2025. Registration number: VN-21977-19. | XXXXXXXXXX | 164861 | UNK | 290237.7905 | Bulgaria | NA |
| 3/28/2024 | 29339990 | Raw materials for producing Irbesartan medicine; USP 2023 standards; batch number 24IR000026; Production date: February 2024; Expiry date: 01/2029; 100% new; Manufacturer: CTX Lifescienes Pvt., Ltd | XXXXXXXXXX | 115 | KGM | 11270 | India | NA |
| 3/25/2024 | 29339990 | Medicinal ingredients: IRBESARTAN. USP/NF Standard 2023. Lot: 10412-230968. Production: September 2023, Date: September 2026. Manufactured by Zhejiang Tianyu Pharmaceutical Co.,Ltd - China. Drug visa number VD-26729-17. | XXXXXXXXXX | 125 | KGM | 10625 | China | NA |
| 3/15/2024 | 30049089 | Modern medicine: IRBEZYD H 150/12.5; box of 3 blisters x 10 tablets; Visa: 890110020524 (VN-15748-12); substance: Irbesartan 150mg; Hydrochlorothiazide 12.5mg; Lot: G400189; Production: January 2024; HD: January 2027 | XXXXXXXXXX | 1080 | UNK | 2516.4 | India | NA |
| 3/11/2024 | 29339990 | Pharmaceutical substance - IRBESARTAN, BP 2023 standard - NL used to produce drugs. Mfg: 08/2023, Expiry date: 07/2028, Batch No: 24IR000009. Manufacturer CTX LIFESCIENCES PRIVATE LIMITED | XXXXXXXXXX | 43 | KGM | 4515 | India | NA |
| 3/5/2024 | 30049089 | Research drug: Irbeartan/HCT STADA150mg/12.5mg (Active ingredient: Irbesartan Hydrochlorothiazid/150mg; 12.5mg). Box/98 tablets. Lot number: 13USSE-NSX:05/2023-HD:04/2028.GPNK: 1599e- 1600e/QLD-KD.NSX:Stada Arzneimitel AG | XXXXXXXXXX | 1 | UNK | 26.3673 | Germany | NA |
| 3/5/2024 | 30049089 | Research drug: Irbeartan/HCT AL 150mg/12.5mg (Active ingredient: Irbesartan Hydrochlorothiazid/150mg; 12.5mg). Box/98 tablets. Lot number: 12WR9D-NSX: 05/2022-HD: 05/2027.GPNK:1598e /QLD-KD.NSX:Stada Arzneimitel AG | XXXXXXXXXX | 4 | UNK | 109.2912 | Germany | NA |
| 3/5/2024 | 30049089 | Research drug: Irbeartan/HCT STADA150mg/12.5mg (Active ingredient: Irbesartan Hydrochlorothiazid/150mg; 12.5mg). Box/98 tablets. Lot number: 13HKXA-NSX:12/2022-HD:11/2027.GPNK: 1599e- 1600e/QLD-KD.NSX:Stada Arzneimitel AG | XXXXXXXXXX | 1 | UNK | 29.9424 | Germany | NA |
| 3/5/2024 | 30049089 | Research drug: Irbeartan/HCT AL 150mg/12.5mg (Active ingredient: Irbesartan Hydrochlorothiazid/150mg; 12.5mg). Box/98 tablets. Lot number: 131AVG-NSX: 05/2022-HD: 05/2027.GPNK:1598e /QLD-KD.NSX:Stada Arzneimitel AG | XXXXXXXXXX | 1 | UNK | 27.3228 | Germany | NA |